Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions.

Poornashree, M; Kumar, Hitesh; Ajmeer, Ramkishan; Jain, Rupshee; Jain, Vikas

Poornashree, M; Kumar, Hitesh; Ajmeer, Ramkishan; Jain, Rupshee; Jain, Vikas.

Afiliação

Poornashree M; Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, 570015, Mysuru, India.
Kumar H; Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, 570015, Mysuru, India.
Ajmeer R; Central Drugs Standard Control Organization, East Zone, 700020, Kolkata, West Bengal, India.
Jain R; Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, 570015, Mysuru, India.
Jain V; Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, 570015, Mysuru, India. vikasjain@jssuni.edu.in.

Mol Biol Rep ; 50(2): 1871-1883, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36513865

Assuntos

Antineoplásicos; Neoplasias; Humanos; Fator 2 Relacionado a NF-E2/metabolismo; Neoplasias/tratamento farmacológico; Neoplasias/genética; Neoplasias/patologia; Antineoplásicos/farmacologia; Carcinogênese; Estresse Oxidativo/genética; Espécies Reativas de Oxigênio/metabolismo; Transdução de Sinais/genética

Palavras-chave

Anti-oncogenic; Anti-oxidation; Dual role; Nrf2; Pro-oncogenic; Therapeutics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Mol Biol Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google